(Q51938632)

18 April 2018

review article

1 reference

title

Borderline personality disorder. (English)

1 reference

18 April 2018

borderline personality disorder

main subject

0 references

5

Martin Bohus

1 reference

18 April 2018

2

Mary C Zanarini

1 reference

18 April 2018

3

Christian Schmahl

1 reference

18 April 2018

4

Marsha M Linehan

1 reference

18 April 2018

1

Klaus Lieb

1 reference

18 April 2018

language of work or name

English

0 references

publication date

1 July 2004

1 reference

18 April 2018

published in

The Lancet

1 reference

18 April 2018

volume

364

1 reference

18 April 2018

issue

9432

1 reference

18 April 2018

page(s)

453-461

1 reference

18 April 2018

The Prevalence of Personality Disorders in a Community Sample

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Estimating the Prevalence of Borderline Personality Disorder in the Community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Functional Impairment in Patients With Schizotypal, Borderline, Avoidant, or Obsessive-Compulsive Personality Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Treatment histories of borderline inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Treatment utilization by patients with personality disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Prevalence and stability of the DSM-III-R personality disorders in a community-based survey of adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Discriminating borderline personality disorder from other axis II disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

The pain of being borderline: dysphoric states specific to borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Experience of aversive tension and dissociation in female patients with borderline personality disorder — a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Characterizing Affective Instability in Borderline Personality Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Cognitive features of borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

An empirical study of psychosis in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Comorbidity of axis I and axis II disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Axis I Comorbidity of Borderline Personality Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Axis I diagnostic comorbidity and borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

The Collaborative Longitudinal Personality Disorders Study: baseline Axis I/II and II/II diagnostic co-occurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Axis II comorbidity of borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Diagnosing personality disorders. A review of issues and research methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

The borderline diagnosis I: psychopathology, comorbidity, and personality structure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

The borderline diagnosis II: biology, genetics, and clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

A twin study of personality disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Phenotypic and genetic structure of traits delineating personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Childhood experiences of borderline patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Reported pathological childhood experiences associated with the development of borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Characteristics of Borderline Personality Disorder: A Canadian Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Childhood sexual and physical abuse in adult patients with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Psychological risk factors for borderline personality disorder in female patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Risk factors for borderline personality in male outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Frequency and correlates of childhood sexual and physical abuse histories in adult female borderline inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Physical and sexual abuse in adolescent girls with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Childhood trauma in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Severity of reported childhood sexual abuse and its relationship to severity of borderline psychopathology and psychosocial impairment among borderline inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Borderline personality disorder symptoms and severity of sexual abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

The borderline patient's intolerance of aloneness: insecure attachments and therapist availability

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

The borderline diagnosis III: identifying endophenotypes for genetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Brain Regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Brain glucose metabolism in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Impulsivity and prefrontal hypometabolism in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Positron emission tomography in female patients with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

A fenfluramine-activated FDG-PET study of borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

A brain MRI study in subjects with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Neural correlates of memories of abandonment in women with and without borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

A positron emission tomography study of memories of childhood abuse in borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

The Amygdala, Fear, and Memory

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Is there a characteristic pattern to the treatment history of clinic outpatients with borderline personality?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Single and Repeated Admissions to a Mental Health Center: Demographic, Clinical and Use of Service Characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

A cohort through the revolving door

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Long-term hospital treatment of borderline patients: a descriptive outcome study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Cognitive-Behavioral Treatment of Chronically Parasuicidal Borderline Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Efficacy of dialectical behavior therapy in women veterans with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Dialectical Behavior Therapy of borderline patients with and without substance use problems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Evaluation of inpatient dialectical-behavioral therapy for borderline personality disorder--a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Dialectical behavior therapy adapted for suicidal adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

The development of a psychodynamic treatment for patients with borderline personality disorder: a preliminary study of behavioral change

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Behavioral treatments of suicidal behaviors. Definitional obfuscation and treatment outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Mental Health Service Utilization by Borderline Personality Disorder Patients and Axis II Comparison Subjects Followed Prospectively for 6 Years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Efficacy of phenelzine and haloperidol in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

A trial of carbamazepine in borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

[Symptom-focussed drug therapy in borderline personality disorder]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Psychopharmacology of borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Clozapine treatment of borderline patients: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Fluoxetine and impulsive aggressive behavior in personality-disordered subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Divalproex in the Treatment of Impulsive Aggression: Efficacy in Cluster B Personality Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Practice parameter for the assessment and treatment of children and adolescents with suicidal behavior. American Academy of Child and Adolescent Psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Clonidine in acute aversive inner tension and self-injurious behavior in female patients with borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Short-Term Diagnostic Stability of Schizotypal, Borderline, Avoidant, and Obsessive-Compulsive Personality Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

The likelihood of recurrence in bipolar affective disorder: the importance of episode recency.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

The Longitudinal Course of Borderline Psychopathology: 6-Year Prospective Follow-Up of the Phenomenology of Borderline Personality Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

A 27-year follow-up of patients with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Long-term follow-up of borderline patients in a general hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Developmental factors in the outcome of borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

Implementing dialectical behavior therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916770-6

7 January 2021

10.1016/S0140-6736(04)16770-6

Identifiers

DOI

1 reference

18 April 2018

1 reference

18 April 2018